These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimising pharmacological maintenance treatment for COPD in primary care. Jones R; Østrem A Prim Care Respir J; 2011 Mar; 20(1):33-45. PubMed ID: 21103801 [TBL] [Abstract][Full Text] [Related]
3. Corticosteroids and chronic obstructive pulmonary disease in the nursing home. Rich A J Am Med Dir Assoc; 2005; 6(3 Suppl):S68-74. PubMed ID: 15890302 [No Abstract] [Full Text] [Related]
4. Are your COPD patients benefiting from best practices? Gianakos D; Kaczynski R J Fam Pract; 2008 Aug; 57(8):532-6. PubMed ID: 18687229 [No Abstract] [Full Text] [Related]
5. Inhaled steroids in COPD: when should they be used? Agusti A; Fabbri LM Lancet Respir Med; 2014 Nov; 2(11):869-871. PubMed ID: 25439566 [No Abstract] [Full Text] [Related]
6. [Pharmacological treatment of COPD. Where are we now?]. Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549 [TBL] [Abstract][Full Text] [Related]
7. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies. Fitzgerald MF; Fox JC Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. Chavez PC; Shokar NK COPD; 2009 Dec; 6(6):446-51. PubMed ID: 19938968 [TBL] [Abstract][Full Text] [Related]
10. A rational approach to single, dual and triple therapy in COPD. Calverley P; Vlies B Respirology; 2016 May; 21(4):581-9. PubMed ID: 26611377 [TBL] [Abstract][Full Text] [Related]
12. Management of chronic stable COPD. Rajan S; Balakrishnan R J Assoc Physicians India; 2012 Feb; 60 Suppl():31-7. PubMed ID: 23155810 [No Abstract] [Full Text] [Related]
13. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine. Contoli M; Corsico AG; Santus P; Di Marco F; Braido F; Rogliani P; Calzetta L; Scichilone N COPD; 2017 Dec; 14(6):641-647. PubMed ID: 29116901 [TBL] [Abstract][Full Text] [Related]
14. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease? López-Campos JL; Calero Acuña C Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023 [TBL] [Abstract][Full Text] [Related]
16. Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians. Rubins JB; Raci E; Kunisaki KM Postgrad Med; 2009 Jan; 121(1):104-12. PubMed ID: 19179818 [TBL] [Abstract][Full Text] [Related]
17. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease? Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776 [TBL] [Abstract][Full Text] [Related]
18. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study. Wurst KE; Shukla A; Muellerova H; Davis KJ COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236 [TBL] [Abstract][Full Text] [Related]
19. Safety of chronic obstructive pulmonary disease medications: a primary care perspective. Hanania NA Postgrad Med; 2011 May; 123(3):72-9. PubMed ID: 21566417 [TBL] [Abstract][Full Text] [Related]
20. Current drug treatment, chronic and acute. Calverley P Clin Chest Med; 2014 Mar; 35(1):177-89. PubMed ID: 24507845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]